These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 8816912

  • 21. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K.
    Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240
    [Abstract] [Full Text] [Related]

  • 22. Transcriptional regulation of the dihydrofolate reductase gene.
    Slansky JE, Farnham PJ.
    Bioessays; 1996 Jan 04; 18(1):55-62. PubMed ID: 8593164
    [Abstract] [Full Text] [Related]

  • 23. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.
    Hilton MJ, Mounghane D, McLean T, Contractor NV, O'Neil J, Carpenter K, Bachenheimer SL.
    Virology; 1995 Nov 10; 213(2):624-38. PubMed ID: 7491786
    [Abstract] [Full Text] [Related]

  • 24. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 10; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 25. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression.
    Chiang SY, Azizkhan JC, Beerman TA.
    Biochemistry; 1998 Mar 03; 37(9):3109-15. PubMed ID: 9485464
    [Abstract] [Full Text] [Related]

  • 26. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
    Majello B, De Luca P, Suske G, Lania L.
    Oncogene; 1995 May 04; 10(9):1841-8. PubMed ID: 7753559
    [Abstract] [Full Text] [Related]

  • 27. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
    Ormondroyd E, de la Luna S, La Thangue NB.
    Oncogene; 1995 Oct 19; 11(8):1437-46. PubMed ID: 7478568
    [Abstract] [Full Text] [Related]

  • 28. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
    Pasteau S, Loiseau L, Arnaud L, Trembleau A, Brun G.
    Oncogene; 1995 Oct 19; 11(8):1475-86. PubMed ID: 7478572
    [Abstract] [Full Text] [Related]

  • 29. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM, Venta-Perez G.
    Cell Growth Differ; 1996 Jan 19; 7(1):31-42. PubMed ID: 8788031
    [Abstract] [Full Text] [Related]

  • 30. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.
    Clin Cancer Res; 2000 Apr 19; 6(4):1488-97. PubMed ID: 10778981
    [Abstract] [Full Text] [Related]

  • 31. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H.
    Oncogene; 1999 Apr 08; 18(14):2299-309. PubMed ID: 10327050
    [Abstract] [Full Text] [Related]

  • 32. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM, Gao CY, Chauthaiwale VM, Zelenka PS.
    Oncogene; 1998 Jan 22; 16(3):399-408. PubMed ID: 9467965
    [Abstract] [Full Text] [Related]

  • 33. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
    Won J, Yim J, Kim TK.
    FASEB J; 2002 Dec 22; 16(14):1943-5. PubMed ID: 12368233
    [Abstract] [Full Text] [Related]

  • 34. Analysis of sequence-specific binding activity of cis-elements in human thymidine kinase gene promoter during G1/S phase transition.
    Good L, Chen J, Chen KY.
    J Cell Physiol; 1995 Jun 22; 163(3):636-44. PubMed ID: 7775606
    [Abstract] [Full Text] [Related]

  • 35. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
    Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A, Campisi J.
    Dev Genet; 1996 Jun 22; 18(2):161-72. PubMed ID: 8934878
    [Abstract] [Full Text] [Related]

  • 36. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S.
    Oncogene; 1997 Jun 19; 14(24):2959-69. PubMed ID: 9205103
    [Abstract] [Full Text] [Related]

  • 37. A new component of the transcription factor DRTF1/E2F.
    Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB.
    Nature; 1993 Mar 04; 362(6415):83-7. PubMed ID: 8446173
    [Abstract] [Full Text] [Related]

  • 38. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.
    Raj GV, Ansari SA, Khalili K.
    Oncogene; 1996 Mar 21; 12(6):1279-88. PubMed ID: 8649830
    [Abstract] [Full Text] [Related]

  • 39. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B, Farmer AA, Lee WH.
    Cell Growth Differ; 1996 Jun 21; 7(6):689-97. PubMed ID: 8780882
    [Abstract] [Full Text] [Related]

  • 40. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F.
    Karlseder J, Rotheneder H, Wintersberger E.
    Mol Cell Biol; 1996 Apr 21; 16(4):1659-67. PubMed ID: 8657141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.